Affiliation:
1. Singapore General Hospital
Abstract
Introduction: Fluid overload is a known complication in patients with diabetes mellitus, particularly those with cardiovascular and/or chronic kidney disease (CKD). This study investigates the impact of fluid overload on healthcare utilisation and its association with diabetes-related complications.
Method: Electronic medical records from the SingHealth Diabetes Registry (2013–2022) were analysed. Hospitalisations due to fluid overload were identified using International Classification of Diseases, 10th Revision (ICD-10) discharge codes. Trends were examined using Joinpoint regression, and associations were assessed with generalised estimating equation models.
Results: Over a period of 10 years, 259,607 individuals treated at primary care clinics and tertiary hospitals were studied. The incidence of fluid overload-related hospitalisations decreased from 2.99% (n=2778) in 2013 to 2.18% (n=2617) in 2017. However, this incidence increased from 2.42% (n=3091) in 2018 to 3.71% (n=5103) in 2022. The strongest associations for fluid overload-related hospitalisation were found with CKD stages G5 (odds ratio [OR] 6.61, 95% confidence interval [CI] 6.26–6.99), G4 (OR 5.55, 95% CI 5.26–5.86) and G3b (OR 3.18, 95% CI 3.02–3.35), as well as with ischaemic heart disease (OR 3.97, 95% CI 3.84–4.11), acute myocardial infarction (OR 3.07, 95% CI 2.97–3.18) and hypertension (OR 3.90, 95% CI 3.45–4.41). Additionally, the prevalence of stage G5 CKD among patients with fluid overload increased between 2018 and 2022.
Conclusion: Our study revealed a significant increase in fluid overload-related hospitalisations and extended lengths of stay, likely driven by severe CKD. This underscores an urgent need for initiatives aimed at slowing CKD progression and reducing fluid overload-related hospitalisations in diabetes patients.
Publisher
Academy of Medicine, Singapore
Reference30 articles.
1. International Diabetes Federation. IDF Diabetes Atlas 2021. https://diabetesatlas.org/atlas/tenth-edition/. Accessed 1 April 2024.
2. Epidemiology & Disease Control Division, Ministry of Health, Singapore; Institute for Health Metrics and Evaluation. The Burden of Disease in Singapore, 1990–2017: An overview of the Global Burden of Disease Study 2017 results. Seattle, WA: IHME, 2019.
3. Institute for Health Metrics and Evaluation (IHME). GBD Compare.https://vizhub.healthdata.org/gbd-compare/. Accessed 18 March 2022.
4. International Diabetes Federation. IDF Diabetes Atlas 10th Edition 2021. Singapore Diabetes Report 2000 — 2045. https://www.diabetesatlas.org/data/en/country/179/sg.html. Accessed 1 April 2024.
5. Tan JK, Salim NNM, Hsiang Lim G, et al. Trends in diabetes related complications in Singapore, 2013–2020: A registry based study. PLoS One 2022;17:e0275920.